NCT04395118撤回不适用
STOP-HCC Evidence-Based Hepatocellular Cancer Prevention Through Treatment of Hepatitis C Virus Infection
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 试验地点
- 2
- 主要终点
- Hepatitis C Screening
研究概览
简要总结
The investigators will conduct a randomized controlled trial comparing two strategies to promote HCV screening, follow-up testing, and treatment among Parkland patients who are 18 years or older who have elevated liver functioning test (LFT) results: in reach with electronic medical record alerts and provider education vs. combination of in reach and provider education plus mailed outreach and patient navigation.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Screening
- 盲法
- Double (Care Provider, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •ages 18 or older
- •elevated liver functioning tests (AST or ALT >35 that are separated by at least one month)
- •≥ 1 outpatient visit during 12 months prior to randomization at Parkland
- •no prior HCV screening (prior HCV antibody, viral load, or genotype).
- •any active medical coverage
- •speaks Spanish or English
排除标准
- •a life expectancy less than one year including any history of metastatic cancer, and those who received a palliative care or hospice referral in the past year
- •history of HCC.
- •non-English or Spanish speakers
- •no address or phone number on file
结局指标
主要结局
Hepatitis C Screening
时间窗: 6 months
Proportion with HCV Ab or HCV VL within 6 months of randomization
次要结局
- Hepatitis C Screening(12 months)
- Hepatitis C Confirmation(3 months)
- Hepatitis C Linkage to Care(6 months)
- Cost Per Patient Screened(3 months)
- Cost Per HCV Diagnosis(12 months)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
STOP HCC: Mailed HCV Treatment Outreach Program for HCC PreventionHepatitis CHepatoCellular CarcinomaNCT03706742University of Texas Southwestern Medical Center12,386
已完成
不适用
Rapid HCV Treatment Access for Persons Who Use DrugsHepatitis C Virus Infection, Response to Therapy ofNCT04677153Johns Hopkins University198
Unknown
不适用
Prospective, Multicenter HCCIS Evaluation StudyHepatocellular CarcinomaNCT02718235University of Regensburg200
终止
不适用
Rapid HCV RNA Testing and LInkage to CareHepatitis C, ChronicNCT04302948University of New Mexico31
进行中（未招募）
2 期
Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC)Hepatocellular CarcinomaNCT05822752AbbVie120